A Detailed Review of Alnylam Pharmaceuticals Earnings in 2023
In 2023, Alnylam Pharmaceuticals reported total global net product revenues of $1.24 billion, representing a 37% increase compared to 2022. Driven lar...
Topic
Explore articles about RNAi Therapeutics.
1 article
In 2023, Alnylam Pharmaceuticals reported total global net product revenues of $1.24 billion, representing a 37% increase compared to 2022. Driven lar...
Ads help support this site. They may be unavailable because of a connection issue, unavailable inventory, or a content blocker. If you use a blocker, allowing this site would help support our work.